# Case Report: Comprehensive management of trichilemmal carcinoma of the lower leg in an elderly patient with comorbidities: a case study on integrated ALA-PDT and surgical excision

**Authors:** Chan Hu, Xiaojing Liu, Mingshun Wu, Caihe Liao, Yan Zhao, Mingyuan Xu, Yongxian Lai, Guolong Zhang

PMC · DOI: 10.3389/fmed.2025.1546359 · Frontiers in Medicine · 2025-03-14

## TL;DR

This case study describes the treatment of a rare skin cancer in an elderly patient with health issues using a combination of photodynamic therapy and surgery.

## Contribution

The paper presents a novel integrated treatment approach for trichilemmal carcinoma in a high-risk elderly patient.

## Key findings

- The patient's TC was confirmed through histopathology and immunohistochemistry, showing high proliferative activity.
- Combining ALA-PDT with surgical excision was effective in treating the tumor while considering the patient's comorbidities.
- The case highlights the importance of a comprehensive treatment strategy for elderly patients with complex health conditions.

## Abstract

Trichilemmal carcinoma (TC), a rare malignancy originating from hair follicle cells, typically affects sun-exposed skin in older individuals and necessitates differential diagnosis from other skin carcinomas. Here, we present one case of trichilemmal carcinoma in a 92-year-old female, admitted to our hospital with a large exophytic red tumor on her right lower leg. Notably, the patient had a history of long-standing hypothyroidism and hypertension, indicating that she was unable to tolerate extensive excision. Histopathology showed outer root sheath hyperplasia with clear cell differentiation and keratinization, alongside increased atypical cells. Immunohistochemistry revealed CK7 and EMA positivity, confirming follicular origin, while negative CK10, CK18, CEA, CK20, and GCDFP-15 excluded other follicular tumors. A high Ki-67 (80%) indicated high proliferative activity, supporting the TC diagnosis. Treatment involved managing her underlying conditions, followed by ALA-PDT and surgical excision for the carcinoma. This case illustrates the challenges in managing trichilemmal carcinoma in elderly patients with multiple comorbidities, emphasizing the importance of a comprehensive approach to treatment.

## Linked entities

- **Proteins:** KRT7 (keratin 7), ETFA (electron transfer flavoprotein subunit alpha), KRT10 (keratin 10), KRT18 (keratin 18), CEACAM5 (CEA cell adhesion molecule 5), KRT20 (keratin 20), PIP (prolactin induced protein), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** hypothyroidism (MONDO:0005420)

## Full-text entities

- **Genes:** KRT10 (keratin 10) [NCBI Gene 3858] {aka BCIE, BIE, CK10, EHK, EHK2, EHK2A}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, KRT18 (keratin 18) [NCBI Gene 3875] {aka CK-18, CYK18, K18}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, PIP (prolactin induced protein) [NCBI Gene 5304] {aka BRST-2, GCDFP-15, GCDFP15, GPIP4}
- **Diseases:** hypothyroidism (MESH:D007037), carcinoma (MESH:D009369), hypertension (MESH:D006973), TC (MESH:C566458), skin carcinomas (MESH:D012878), hyperplasia (MESH:D006965)
- **Chemicals:** ALA (MESH:D000409)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11949778/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11949778/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC11949778/full.md

---
Source: https://tomesphere.com/paper/PMC11949778